Lukas Bubendorf

29.7k total citations · 2 hit papers
326 papers, 17.5k citations indexed

About

Lukas Bubendorf is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Lukas Bubendorf has authored 326 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 181 papers in Pulmonary and Respiratory Medicine, 116 papers in Oncology and 99 papers in Molecular Biology. Recurrent topics in Lukas Bubendorf's work include Lung Cancer Treatments and Mutations (85 papers), Cancer Genomics and Diagnostics (66 papers) and Prostate Cancer Treatment and Research (65 papers). Lukas Bubendorf is often cited by papers focused on Lung Cancer Treatments and Mutations (85 papers), Cancer Genomics and Diagnostics (66 papers) and Prostate Cancer Treatment and Research (65 papers). Lukas Bubendorf collaborates with scholars based in Switzerland, United States and Germany. Lukas Bubendorf's co-authors include Guido Sauter, Michael J. Mihatsch, Juha Kononen, Peter Schraml, Thomas C. Gasser, Holger Moch, J. Torhorst, Maarit Bärlund, Stephen B. Leighton and Niels Willi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lukas Bubendorf

314 papers receiving 17.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1998 3.2k citations Lukas Bubendorf, Michael J. Mihatsch et al. profile →
Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

2000 1.4k citations Lukas Bubendorf, Guido Sauter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lukas Bubendorf Switzerland	65	8.3k	6.8k	6.4k	4.0k	2.1k	326	17.5k
Yoshitaka Fujii Japan	58	7.7k 0.9×	8.3k 1.2×	9.1k 1.4×	4.0k 1.0×	2.0k 1.0×	439	19.9k
Ronald Simon Germany	63	6.9k 0.8×	5.2k 0.8×	3.9k 0.6×	3.4k 0.9×	1.6k 0.8×	357	13.5k
Nicola Normanno Italy	63	8.4k 1.0×	10.5k 1.5×	5.6k 0.9×	4.5k 1.1×	1.2k 0.6×	362	18.5k
Élisabeth Brambilla France	75	8.1k 1.0×	7.7k 1.1×	7.1k 1.1×	3.4k 0.9×	1.7k 0.8×	226	17.9k
Glen Kristiansen Germany	79	12.2k 1.5×	6.5k 1.0×	5.5k 0.9×	6.5k 1.6×	2.8k 1.4×	540	22.1k
Lawrence D. True United States	61	6.1k 0.7×	3.5k 0.5×	8.0k 1.2×	3.3k 0.8×	2.0k 0.9×	277	15.9k
Scott A. Tomlins United States	70	11.8k 1.4×	4.2k 0.6×	11.4k 1.8×	6.8k 1.7×	2.2k 1.1×	264	22.6k
Richard Görlick United States	71	8.8k 1.1×	5.7k 0.8×	6.9k 1.1×	4.1k 1.0×	1.2k 0.6×	363	18.2k
Allen M. Gown United States	68	5.0k 0.6×	6.4k 0.9×	3.8k 0.6×	3.7k 0.9×	2.2k 1.1×	191	16.1k
Heinz Höfler Germany	71	8.3k 1.0×	6.5k 1.0×	4.6k 0.7×	3.7k 0.9×	4.3k 2.1×	408	19.1k

Countries citing papers authored by Lukas Bubendorf

Since Specialization

Citations

This map shows the geographic impact of Lukas Bubendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Bubendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Bubendorf more than expected).

Fields of papers citing papers by Lukas Bubendorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Bubendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Bubendorf. The network helps show where Lukas Bubendorf may publish in the future.

Co-authorship network of co-authors of Lukas Bubendorf

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Bubendorf. A scholar is included among the top collaborators of Lukas Bubendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Bubendorf. Lukas Bubendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gorbokon, Natalia, Maximilian Lennartz, Sarah Minner, et al.. (2025). Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas. Cancers. 17(7). 1205–1205. 2 indexed citations

Vetter, Roman, Kevin A. Yamauchi, Yifan Wang, et al.. (2025). Morphometry and mechanical instability at the onset of epithelial bladder cancer. Nature Physics. 21(2). 279–288. 3 indexed citations

Alborelli, Ilaria, Melanie Demes, Peter J. Wild, et al.. (2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. SHILAP Revista de lepidopterología. 6(3). 19–19.

Bubendorf, Lukas, et al.. (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer. Canadian Urological Association Journal. 18(7). E233–E239. 1 indexed citations

Jain, Deepali, et al.. (2024). Diagnostic and Predictive Immunocytochemistry in Lung Cancer. Acta Cytologica. 69(1). 1–8.

Vlajnic, Tatjana, Obinna Chijioke, Spasenija Savic Prince, et al.. (2024). Loss of MTAP Expression by Immunohistochemistry Is a Surrogate Marker for Homozygous 9p21.3 Deletion in Urothelial Carcinoma. Modern Pathology. 37(6). 100495–100495. 4 indexed citations

Vlajnic, Tatjana, David C. Müller, Christian Ruiz, et al.. (2023). Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer. Cancer Reports. 7(2). e1953–e1953. 1 indexed citations

Soo, Ross A., et al.. (2023). EP06.03-10 HER3 Expression in Archived Tissue Samples from Patients with NSCLC Across Various Genomic Subtypes and Characteristics. Journal of Thoracic Oncology. 18(11). S486–S486. 1 indexed citations

Field, Andrew, Martha B. Pitman, Ian A. Cree, et al.. (2023). The rationale for the development and publication of the World Health Organization reporting systems for cytopathology and a brief overview of the first editions of the lung and pancreaticobiliary systems. Cancer Cytopathology. 131(12). 751–761. 6 indexed citations

10.

Canberk, Şule, Andrew Field, Lukas Bubendorf, et al.. (2023). A brief review of the WHO reporting system for lung cytopathology. Journal of the American Society of Cytopathology. 12(4). 251–257. 12 indexed citations

11.

Kerr, Keith M., Lukas Bubendorf, Fernando López‐Ríos, et al.. (2023). Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. Histopathology. 84(3). 429–439. 8 indexed citations

12.

Calgua, Byron, Clémentine Le Magnen, Salvatore Piscuoglio, et al.. (2023). Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. Cancers. 16(1). 45–45. 1 indexed citations

13.

Alborelli, Ilaria, Obinna Chijioke, Spasenija Savic Prince, et al.. (2020). Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients. Lung Cancer. 149. 84–89. 17 indexed citations

14.

Prendeville, Susan, Daniel M. Berney, Lukas Bubendorf, et al.. (2019). Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology. Histopathology. 74(6). 844–852. 5 indexed citations

15.

Magnen, Clémentine Le, Lukas Bubendorf, Cyrill A. Rentsch, et al.. (2013). Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer. Clinical Cancer Research. 19(19). 5361–5371. 67 indexed citations

16.

Ruiz, Christian, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2011). Advancing a clinically relevant perspective of the clonal nature of cancer. Proceedings of the National Academy of Sciences. 108(29). 12054–12059. 90 indexed citations

17.

Thunnissen, Erik, Keith M. Kerr, Felix Herth, et al.. (2011). The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer. 76(1). 1–18. 167 indexed citations

18.

Bubendorf, Lukas, Peter Dalquen, & Sinisa Savic. (2009). Zytologie der ableitenden Harnwege: Zwischen Zweifel und Gewissheit. Der Pathologe. 30. 173–178. 2 indexed citations

19.

Tan, Shyh‐Han, Ayush Dagvadorj, Feng Shen, et al.. (2008). Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer Cells. Cancer Research. 68(1). 236–248. 88 indexed citations

20.

Wagner, U., Lukas Bubendorf, Thomas C. Gasser, et al.. (1997). Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.. Europe PMC (PubMed Central). 151(3). 753–9. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact